Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Abstract Background Hepatitis C virus (HCV) infection is considered one of the main causes of chronic liver disease around the world. Liver biopsy has been believed to be the gold standard for the assessment of the degree of liver fibrosis. Thus, there is a need to improve non-invasive evaluation of...

Full description

Bibliographic Details
Main Authors: Nancy Abdel Fattah Ahmed, Ahmed Galal Deiab, Ahmad Shawki Mohammad Hasan, Ahmad Mohamed Yousry Abd Elbaky
Format: Article
Language:English
Published: SpringerOpen 2020-08-01
Series:Egyptian Liver Journal
Subjects:
Serum autotaxin
Direct-acting antivirals
Hepatic fibrosis
Online Access:http://link.springer.com/article/10.1186/s43066-020-00051-x

Internet

http://link.springer.com/article/10.1186/s43066-020-00051-x

Similar Items